Page 1,700«..1020..1,6991,7001,7011,702..1,7101,720..»

Hormone Replacement Therapy – What You Need to Know

Posted: October 22, 2016 at 6:43 pm

This material must not be used for commercial purposes, or in any hospital or medical facility. Failure to comply may result in legal action.

What is it? Hormone replacement therapy (HRT) is a treatment for women who have low hormone levels, like a woman going through menopause. HRT is also called estrogen (es-tro-jin) replacement therapy or ERT. With HRT a woman takes estrogen, and often progestin (pro-jes-tin), to help the symptoms caused by low hormone levels in her body.

What are hormones and how do they work?

What are the reasons I may not have enough estrogen?

What are the signs and symptoms of a low estrogen level? You can have physical and emotional changes when your estrogen level is low.

Will HRT help these symptoms? You may choose to take HRT to help or prevent the symptoms of low estrogen. Hot flashes and night sweats will occur less often and may possibly go away if you take estrogen. Estrogen helps prevent vaginal dryness and thinning of the tissue inside the vagina. Your chances of breaking a bone are much lower if you take estrogen. HRT may also improve your mood and memory. HRT may reduce your risk of heart disease.

Is HRT safe?

Are there side effects with HRT? Following are possible side effects of HRT.

How long do I need to take HRT? Bone loss is highest during the early years after menopause. To get the best results, HRT should start soon after the beginning of menopause. You should continue with HRT for at least 7 to 10 years. You and your caregiver can decide how long you should take HRT. You will need long-term treatment if you are trying to prevent heart disease or osteoporosis. Bone loss will begin right away when you stop taking HRT.

How do I take HRT?

Are there other ways to prevent bone loss or heart disease without HRT? Eating foods that are rich in calcium and low in fat is one way to control bone loss and heart disease. Caregivers may give you medicine to prevent bone loss or heart disease. Other ways to prevent bone loss and heart disease are to exercise regularly and to limit the amount of alcohol that you drink. You should not have more than 1 drink a day. A drink is 1 1/2 ounces of whiskey, 5 ounces of wine, or 12 ounces of beer (regular or light). If you smoke, you should quit.

How often should I see my caregiver if I take HRT? Call your caregiver if you are bleeding from your vagina or have other side effects that are bothering you. You should see your caregiver every year for a check up. Your caregiver may want you to have the following tests.

Where can I get more information about HRT? You can call or write the following organizations for more information.

You have the right to help plan your care. To help with this plan you must learn about hormone replacement therapy. You can then discuss the treatment options with caregivers. Work with them to decide what care will be used to treat your decreasing estrogen levels. You always have the right to refuse treatment.

Visit link:
Hormone Replacement Therapy - What You Need to Know

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy – What You Need to Know

Hormone Replacement Therapy – Teresa knight

Posted: October 22, 2016 at 6:43 pm

Lets put menopausal estrogen use in an historical perspective: Throughout history and as women have become over-nourished, the age of puberty has become younger. The age of menopause, however, has stayed the same, on average about 52. When the ancient Egyptians were going through menopause, the average age of death was ten years before menopause. Now the average age of death for women is 78 to 80. We live nearly half our lives past menopause. In the 1960s, scientists discovered hormone replacement and its benefits: improved cognition, less arthritis, stronger bones, better sleep, and better sex.

For decades now, millions of women entering menopause in America were prescribed Premarin or Prempro without much question. Premarin, a mixture of estrogens derived from the urine of a pregnant horse, and Prempro, a combination of horse estrogens and synthetic progesterone, served to replace female hormones that naturally dissipate in peri-menopausal and menopausal women, primarily estrogen and progesterone.

Healthcare providers and their female patients were shocked to learn that hormone replacement therapy was not as safe as they had once thought after receiving the data from the Womens Health Initiative. The results of the study suggested that this type of hormone replacement therapy did not protect a woman from getting heart disease, and actually increased her risk of breast cancer, blood clotting and possible stroke. A reanalysis of this study was completed in 2007 further suggesting that actual heart disease risk factors was dependent upon what age a woman was when she began hormone replacement therapy. These results still remain controversial. Again, in 2008 the study underwent a reanalysis which concluded that hormone therapy is associated with an increased risk of stroke, regardless of when hormone replacement therapy is initiated.

There were major problems with the study. Sponsored by Wyeth, a major producer of HRT, the WHI looked at whether hormone replacement could prevent heart attacks, since estrogen is protective for heart disease. They set up the study as a placebo-control, double-blind study. The problem is, women who are on HRT know it, so they specifically chose women who werent having night sweats or hot flashes. The only women who fit that criterion had an average age of 63, more than 10 years passed menopause. By that age, permanent changes from estrogen deprivation, such as hardening of the arteries, have already occurred. Giving HRT at that point is too late to prevent it and can actually make it worse, so people had more heart attacks and strokes. If supplemention starts early in the mid-40s when menopausal symptoms first start, it has the potential to prevent heart disease. The recent increased concern about HRT is from following women in the original study who were on average ten-plus years beyond menopause, taking oral HRT for at least 15 years, in higher doses than are prescribed today, and taking a combination of estrogen and progestin. Even given that, the increase in breast cancer and death are very slight. None of the non-oral delivery systems or current age and dosage recommendations was studied.

Unfortunately many practitioners often label all hormone replacement therapy the same. What this means is that many women are often advised that the risks apply regardless of the type of hormones. The reality of the study and the reanalysis showed associated risks only for oral conjugated equine estrogens and synthetic progestins, not bio-identical hormones.

Bioidentical, non-oral estrogen supplementation is a different animal. Bioidentical hormones are made in the lab, and once they get into the body, your body recognizes them as their own. The only way that is likely to happen is via a non-oral route. Taking any estrogen orally requires processing in the liver before it goes to the rest of the body. That processing changes the oral medication into something else, a by-product not recognized as the youthful estrogen your body likes: estradiol. Transdermal creams bypass the liver.

Objectively, HRT is the best way to protect bones. Osteoporosis treatment is only second-best because while it increases the density of bones, it makes them very brittle. Its a different architecture.

Meanwhile, women continue to come to us every day, completely confused and even scared about hormone replacement. We have always been dedicated to clearing up misconceptions about hormone replacement therapy, and . providing women with alternatives to conventional hormone replacement, including bio-identical hormones Because there havent been many definitive studies done on bioidentical hormone replacement therapy, we do not know exactly what the risks are for every woman taking it. What we do know is that from the results of studies that have looked at bio-identical hormone replacement therapy, and from what has been seen in the clinical practice of prescribing bio-identical hormone replacement to patients, bio-identical hormone replacement therapy does not appear to have the same side effects consistent with conventional hormone replacement therapy, in particular transdermal forms.

Bio-identical hormones have been shown to share the exact same molecular structure with those found in our bodies. Unlike conventional or synthetic forms of hormone replacement therapy, they are not patented and sold by pharmaceutical companies. That is the main reason why there have been very few studies to evaluate their risks and benefits. Bio-identical hormones are not as profitable as the conventional synthetic forms. In the future, more studies will be done to help clarify the benefits or disadvantages associated with bio-identical hormone replacement therapy.

There has have been serious efforts made to shut down compounded bio-identical hormone replacement therapy as an option for women. The belief of our office is that women deserve to know all of their options and alternatives surrounding hormone replacement therapy. They need to be fully informed of everything we have learned and have access to these options when they need them.

In order to find answers to your questions about bio-identical hormone replacement therapy and how to decide if that could be a better choice for you, please call our office at (314) 292-7080 to set up a consultation with one of practitioners. We here at Womens Health Specialists of St. Louis are dedicated to your complete healthcare needs. Educating yourself as much as possible will always lead you to better health. Being informed is the only way you can decide the right decision for yourself.

Follow this link:
Hormone Replacement Therapy - Teresa knight

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy – Teresa knight

Bioidentical Hormone Replacement Therapy | Menopause Doctor …

Posted: October 22, 2016 at 6:43 pm

RejuvinAge, a Virginia Beach Bioidentical Hormone Replacement Center, focuses on Individualizing Hormone Therapy for Women and Men. RejuvinAge specializes in Hormone Replacement for approved indications of Menopause for women and Low Testosterone Replacement Therapy for men.

Women and men are very comfortable and confident in our boutique setting for hormone replacement. Programs are individualized; one size does not fit all. Every program is physician managed; appointments are always on time with our hormone replacement doctor, Jennifer Krup, M.D. Personalized care is our focus; we recognize the importance of one on one attention.

Focusing on menopause for women, Dr. Krup encourages every woman to embrace this phase of their life.Understanding BHRT empowers women with the knowledge to make the right decisions and successfully manage menopausal symptoms. Understanding appropriate dosages, appropriate routes of administration and the appropriate length of treatment for each woman keeps RejuvinAge in the forefront

Offering Low T options for men, Dr. Krup will help determine ifTestosterone Replacement Therapyis right for you. Making the right choice for TRT is an important decision for men today.

The RejuvinAge approach to Bio Identical Hormone Replacement for women and men is based on sound medicine. Hormone optimization takes patience, compliance, great communication and a partnership with you. Our Virginia Beach Hormone Replacement center is easily accessible to the surrounding cities of Norfolk, Chesapeake, Hampton Newport News, Williamsburg and beyond. Make your appointment today-meet Dr. Krup in her Virginia BeachBio-Identical Hormone Center.

Link:
Bioidentical Hormone Replacement Therapy | Menopause Doctor ...

Posted in Hormone Replacement Therapy | Comments Off on Bioidentical Hormone Replacement Therapy | Menopause Doctor …

Rhode Island Hospital Unveils New COBRE Center for Stem …

Posted: October 22, 2016 at 6:41 pm

3/27/2013

Current stem cell studies include research into new treatments for leukemia, lymphoma and liver, kidney and bone marrow damage

Rhode Island Hospital is expanding its research space in the citys bio-med-focused Knowledge District with the opening of a new hematology-oncology laboratory, the COBRE Center for Stem Cell Biology. The lab, which is located in Lifespans research hub the Coro Building -- provides researchers with the state-of-the-art technology needed to support ongoing research in the areas of cancer, tissue injury and basic stem cell biology.

The new 11,000-square-foot hematology-oncology research lab was made possible by a grant from the National Institutes of Health (NIH). The NIH conferred more than $300,000 to Peter Quesenberry, MD, director of hematology oncology at Rhode Island and The Miriam hospitals, specifically for the construction of the new lab.

This new lab space will help us to further study the use of stem cells for the treatment of many illnesses various forms of cancer, tissue and organ damage and much more, Quesenberry said. Creating this research hub provides our researchers with the best possible resources, and places us in close proximity to the hospitals, allowing us to more appropriately collaborate with our peers, and truly bring research from the bench to the bedside.

Quesenberry continued, Additionally, by working closely with the physicians, we are developing new studies that stem from the patient essentially, creating research in reverse, from the bedside to the bench, in an effort to develop new treatments for all-too-common and debilitating illnesses.

The cancer studies being conducted are directed toward revising drug resistance in prostate cancer, chronic myelocytic leukemia and breast cancer. Additionally, cutting-edge studies to develop better treatments for prostate and breast cancer are being conducted, as are studies of mesenchymal stem cells for their ability to reverse pulmonary hypertension. The laboratory also will support research in novel anti-cancer treatments for pediatric and adult malignancies, and will continue to examine therapeutic mechanisms underlying refractory leukemia and lymphoma. The new lab space can accommodate 14 laboratory benches, and can accommodate 10 funded investigators, as well as their technicians and students.

Part of Rhode Island Hospitals mission is to be at the forefront of patient care by creating, applying and sharing the most advanced knowledge in health care, said Peter Snyder, PhD, senior vice president and chief research officer for Lifespan.. One of the ways we do that is by providing our researchers with the tools they need to conduct cutting-edge research in order to discover and create improved diagnostic measures and treatments. This new research space is the first step in a major renovation project at the Coro Building that we believe will serve as a focal point for clinical research in Rhode Island, and propel us to the forefront of academic medicine in the U.S.

More here:
Rhode Island Hospital Unveils New COBRE Center for Stem ...

Posted in Rhode Island Stem Cells | Comments Off on Rhode Island Hospital Unveils New COBRE Center for Stem …

Regenerative Medicine

Posted: October 21, 2016 at 6:44 am

This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site.

There are many reasons why a cookie could not be set correctly. Below are the most common reasons:

This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. To provide access without cookies would require the site to create a new session for every page you visit, which slows the system down to an unacceptable level.

This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured.

In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a website to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it.

Read the original:
Regenerative Medicine

Posted in Regenerative Medicine | Comments Off on Regenerative Medicine

Newcastle Hospitals – Molecular Genetics

Posted: October 21, 2016 at 6:44 am

Contact: (0191) 241 8600 - Dr David Bourn, Head of Laboratory, Molecular Genetics

The molecular laboratory service provides genetic diagnosis for those families suffering from inherited conditions caused by mutation of specific single genes.Testing is performed using a variety of DNA analysis techniques to identify causative mutations or to track defective genes through families.

The Molecular Genetics Laboratory operates within the Professional Guidelines of the Clinical Molecular Genetics Society (CMGS).

The laboratory is accredited by Clinical Pathology Accreditation

Clinical scientists and MLSO staff are State Registered with the Health Professions Council after the required period of training.

The Molecular Genetics Laboratory participates in the following external quality assurance schemes:

Northern Genetics Service Institute of Genetic Medicine Central Parkway Newcastle upon Tyne NE1 3BZ

Tel: 0191 241 8600

The laboratory operates Monday to Friday between the hours of 08.30 and 17.00.For the receipt and analysis of very urgent samples outside these hours, please make special arrangements with the laboratory.

Head of Laboratory

Dr David Bourn

telephone: 0191 241 8600

Read this article:
Newcastle Hospitals - Molecular Genetics

Posted in Molecular Genetics | Comments Off on Newcastle Hospitals – Molecular Genetics

MCW: Microbiology and Molecular Genetics Department

Posted: October 21, 2016 at 6:44 am

The mission of our faculty is to conduct innovative and impactful research in Microbiology, Immunology, and Molecular Genetics and to train students and postdoctoral fellows for careers as biomedical scientists. Our faculty also instruct in the Graduate School of Biomedical Sciences and the Medical School and often collaborate with clinical scientists to facilitate the translation of bench to bedside therapies to treat human diseases. Our students acquire professional training while carrying out independent research projects in microbial pathogenesis and physiology, the immune response, and host interactions with microbial pathogens. Our administrative and research staff strive to support the research, teaching and service activities of our students and faculty.

Contact information for faculty members in the department, including email addresses and room numbers, can be found on the faculty pages.

Medical College of Wisconsin Department of Microbiology and Molecular Genetics BSB - 2nd Floor - Room 273 8701 Watertown Plank Road Milwaukee, WI 53226

(414) 955-8253 | (414) 955-6535 (fax)

The department is located on the second floor of the Basic Science Building at 8701 W. Watertown Plank Road.

More here:
MCW: Microbiology and Molecular Genetics Department

Posted in Molecular Genetics | Comments Off on MCW: Microbiology and Molecular Genetics Department

Integrative Medicine – The Bravewell Collaborative

Posted: October 21, 2016 at 6:44 am

Integrative medicine is an approach to care that seeks to integrate the best of Western scientific medicine with a broader understanding of the nature of illness, healing and wellness. Easily incorporated by all medical specialties and professional disciplines, and by all health care systems, its use not only improves care for patients, it also enhances the cost-effectiveness of health care delivery for providers and payors.

A practical strategy, integrative medicine puts the patient at the center of the care and addresses the full range of physical, emotional, mental, social, spiritual and environmental influences that affect a person's health.By treating the whole person, both the patient's immediate needs as well as the effects of the long-term and complex interplay between a range of biological, behavioral, psychosocial and environmental influences are addressed. This process enhances the ability of individuals to not only get well, but most importantly, to stay well.

The defining principles of integrative medicine are:

The patient and practitioner are partners in the healing process.

All factors that influence health, wellness and disease are taken into consideration.

The care addresses the whole person, including body, mind, and spirit in the context of community.

Providers use all appropriate healing sciences to facilitate the body's innate healing response.

Effective interventions that are natural and less invasive are used whenever possible.

Because good medicine is based in good science, integrative medicine is inquiry-driven and open to new models of care.

Alongside the concept of treatment, the broader concepts of health promotion and the prevention of illness are paramount.

The care is individualized to best address the persons unique conditions, needs and circumstances.

Practitioners of integrative medicine exemplify its principles and commit themselves to self-exploration and self-development.

Gofor the report, "Integrative Medicine: Improving Health Care for Patients and Health Care Delivery for Providers and Payors"

Gofor the report, "The Efficacy and Cost-Effectiveness of Integrative Medicine"

Goto learn about The Summit on Integrative Medicine and the Health of the Public and listen to the presentations

Goto read stories from patients who have been helped with integrative medicine

Here is the original post:
Integrative Medicine - The Bravewell Collaborative

Posted in Integrative Medicine | Comments Off on Integrative Medicine – The Bravewell Collaborative

Integrative Medicine | University of Michigan Health System

Posted: October 21, 2016 at 6:44 am

The University of Michigan is committed to the thoughtful and compassionate combination of complementary therapies and conventional medicine through the activities of research, education, clinical services and community partnerships.

We offer our patients the following services:

We provide primary care services for the whole family focusing on integrative medicine, anthroposophic medicine and holistic medicine. An integrative medicine plan is created that suits each individual's unique needs, offering specific recommendations for mind, body, spirit and emotion that optimize health. Integrative therapies such as holistic nutrition, relaxation techniques, acupuncture, massage, herbs and supplements are blended with the best of medical science and technology.

Holistic medicine is the art and science that addresses the whole person and uses both conventional and complementary therapies to prevent and treat disease, but most importantly to promote optimal health. Holistic physicians work together to transform health care to integrate all aspects of well being, including physical, environmental, mental, emotional, spiritual and social health, thereby contributing to the healing of ourselves and of our planet.

Anthroposophic medicine views health as a matter of balancing the mind, body, and spirit. It is centered on the idea that human beings are composed of the interactions of physical body, inner life body, mind, emotions and self-awareness.

At the University of Michigan, we investigate the use of complementary alternative medicine therapies in the prevention, management and treatment of conditions such as heart disease, diabetes, cancer and rheumatologic disorders. Alternative therapies investigated include acupuncture, nutrition, herbal medicine, spirituality, mind-body therapies, and energy medicine. Lifestyle change programs that include stress reduction and respite in nature are also actively researched.

To make an appointment, please call 734-998-7390.

Original post:
Integrative Medicine | University of Michigan Health System

Posted in Integrative Medicine | Comments Off on Integrative Medicine | University of Michigan Health System

Stem Cell Research | Environmental Health and Safety

Posted: October 21, 2016 at 6:41 am

Application

On March 9, 2009, President Barack Obama issued an Executive Order 13505: Removing Barriers to Responsible Scientific Research Involving Human Stem Cells. The National Institutes of Health Guidelines for Human Stem Cell Research (Guidelines) implement this Executive Order as it pertains to extramural NIH-funded stem cell research. The Guidelines establish policy and procedures under which the NIH will fund research involving human embryonic stem cells (hESCs) and certain uses of human induced pluripotent stem cells (iPSCs) and work to ensure such research is ethically responsible, scientifically worthy and conducted in accordance with applicable law.

The University of Iowa is responsible for ensuring that all stem cell research conducted at or sponsored by the University complies with theGuidelines. Compliance authority on campus is placed with the Human Pluripotent Stem Cell Committee (hPSCC). The hPSCC reviews stem cell research and approves those projects in conformity with the Guidelines and in accordance with the general principles expressed in the Guidelines for Human Embryonic Stem Cell Research (National Academies of Science, 2005) and its subsequent amendments. The hPSCC is appointed by and advises the Assistant Vice President for Research Compliance.

Researchers at the University of Iowa must be in compliance with the Guidelines, irrespective of the source of funding.

The eligibility of hESCs for research purposes is governed by the NIH. Researchers may use hESCs that are posted on the NIH Registry or they may establish eligibility for NIH Funding by submitting a compliance of assurance with Section II (A) of the Guidelines. The Institutional Review Board (IRB) will review the compliance of assurance and any part of a research project that meets the federal definitions of human subject research and/or clinical investigation.

Principal investigators (PIs) involved in stem cell research are responsible for:

The University of Iowa follows the procedures and policies as outlined in the Guidelines and expressed in the Guidelines for Human Embryonic Stem Cell Research and its subsequent amendments. These policies and procedures, and the review procedures of the hPSCC, are summarized in hPSCCs Policy and Standard Operating Procedures.

Registration may be required with the Institutional Animal Care and Use Committee (IACUC) if the project involves animal use and/or with the Institutional Biosafety Committee (IBC) if the project involves recombinant DNA.

The hPSCC will review for compliance all submitted hPSC Registration Documents and an approval/disapproval letter will be sent to the PI. The hPSCC will prohibit the initiation of experiments that are ineligible for NIH Funding. Prohibited experiments include:

The hPSCC will review all correspondence between the PI, IRB, IBC, IACUC and NIH, where applicable, in addition to the hPSC Registration Document.

International Society for Stem Cell Research International Society for Stem Cell Research Stem Cell Treatments National Institutes of Health Resource for Stem Cell Information Office of Animal Resources University of Iowa eIBC for Recombinant DNA Registration

View original post here:
Stem Cell Research | Environmental Health and Safety

Posted in Iowa Stem Cells | Comments Off on Stem Cell Research | Environmental Health and Safety

Page 1,700«..1020..1,6991,7001,7011,702..1,7101,720..»